Professional Role and Responsibilities
Emily Ricketts currently serves as Vice President of the Innovation & Integration Office at WCG Clinical, a leading organization in clinical research services. In this capacity, she oversees large-scale operational strategy and integration initiatives aimed at driving innovation across WCG’s clinical solutions. Her role involves managing multi-million dollar budgets and leading cross-functional teams, highlighting her capacity to influence both tactical execution and strategic development within the company.
Previously, she has held positions such as Vice President, Operational Strategy and Planning, and Vice President, Patient Advocacy and Clinical Research Diversity, further emphasizing her broad leadership scope in clinical operations, diversity initiatives, and patient engagement. Her responsibilities incorporate advancing clinical research diversity and patient advocacy, aligning with evolving industry priorities and regulatory trends.
Expertise and Skills
Emily holds an MSc degree and is certified as a PMP (Project Management Professional) and a CIP (Certified IRB Professional), underscoring her qualifications in project leadership and regulatory compliance within clinical research environments. She has completed advanced professional development at Innovation Labs during 2022–2023, a program focused on business innovation, process improvement, and clinical development.
Her skill set encompasses:
- Business Innovation
- Process Improvement
- Clinical Development
- Operational Strategy
- Patient Advocacy
- Diversity in Clinical Research
These competencies support WCG’s commitment to optimizing clinical trial operations and enhancing study diversity and inclusion.
Industry Influence and Thought Leadership
Emily is recognized as an innovative clinical research leader with a significant presence in professional forums such as the DIA (Drug Information Association) 2021 Global Annual Meeting, where she served as a chair and speaker. She has contributed to WCG’s published insights on clinical research trends and operational strategies, particularly focused on patient advocacy and diversity in drug development programs, as reflected in WCG’s 2022 clinical research insights report.
Academic and Research Contributions
Prior to her current executive roles, Emily has demonstrated involvement in research related to precision health approaches, particularly in psychiatric disorders such as bipolar disorder, with affiliations to the University of California, Los Angeles (UCLA) where she has engaged with scientific communities and contributed to research advancements. Although some publications and details pertain to an Emily Ricketts with a Ph.D. at UCLA, these appear to be a different individual and are thus excluded from this report focusing on the WCG executive.
Location and Organizational Context
Emily is based in the Greater Philadelphia area, consistent with WCG Clinical’s headquarters and operational centers. WCG is known for its global leadership in clinical trial quality and efficiency, providing integrated solutions including ethical review, site optimization, and data-driven insights to biopharmaceutical companies, CROs, and research sites.
Organizational Leadership Environment
At WCG, Emily operates among a robust executive leadership team that includes the CEO Sam Srivastava, Chief Operations Officer Mark McDonald, Chief Growth Officer Stacey Yount, and other key officers responsible for finance, compliance, technology, and marketing. This leadership is complemented by an external advisory board comprised of distinguished experts in medicine and clinical research, supporting WCG's strategic direction and commitment to innovation.
In summary, Emily Ricketts is a senior executive leader at WCG Clinical with expertise in operational strategy, innovation, clinical research diversity, and patient advocacy. Her background in project and process management and leadership in integration initiatives positions her as an influential decision-maker driving strategic growth and innovation at WCG. This profile reflects her capacity to impact complex clinical trial environments and foster organizational advancements aligned with evolving industry demands.
